z-logo
open-access-imgOpen Access
Increased Mitotic Rate Coincident with Transient Telomere Lengthening Resulting from Pim‐1 Overexpression in Cardiac Progenitor Cells
Author(s) -
Cottage Christopher T.,
Neidig Lauren,
Sundararaman Balaji,
Din Shabana,
Joyo Anya Y.,
Bailey Brandi,
Gude Natalie,
Hariharan Nirmala,
Sussman Mark A.
Publication year - 2012
Publication title -
stem cells
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.159
H-Index - 229
eISSN - 1549-4918
pISSN - 1066-5099
DOI - 10.1002/stem.1211
Subject(s) - telomere , telomerase , biology , mitosis , microbiology and biotechnology , regeneration (biology) , progenitor cell , stem cell , cancer research , population , genetics , dna , gene , medicine , environmental health
Cardiac regeneration following myocardial infarction rests with the potential of c‐kit+ cardiac progenitor cells (CPCs) to repopulate damaged myocardium. The ability of CPCs to reconstitute the heart is restricted by patient age and disease progression. Increasing CPC proliferation, telomere length, and survival will improve the ability of autologous CPCs to be successful in myocardial regeneration. Prior studies have demonstrated enhancement of myocardial regeneration by engineering CPCs to express Pim‐1 kinase, but cellular and molecular mechanisms for Pim‐1‐mediated effects on CPCs remain obscure. We find CPCs rapidly expand following overexpression of cardioprotective kinase Pim‐1 (CPCeP), however, increases in mitotic rate are short‐lived as late passage CPCePs proliferate similar to control CPCs. Telomere elongation consistent with a young phenotype is observed following Pim‐1 modification of CPCeP; in addition, telomere elongation coincides with increased telomerase expression and activity. Interestingly, telomere length and telomerase activity normalize after several rounds of passaging, consistent with the ability of Pim‐1 to transiently increase mitosis without resultant oncogenic transformation. Accelerating mitosis in CPCeP without immortalization represents a novel strategy to expand the CPC population in order to improve their therapeutic efficacy. S TEM C ELLS 2012;30:2512–2522

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here